Award recordCONTRACT

ASTRAZENECA LIMITED PARTNERSHIP

PIID VA26012F0102· VHA· 260-NETWORK CONTRACT OFFICE 20· 6505 · DRUGS AND BIOLOGICALS· FY2012· $119,291 net obligations· UEI FBWCB39K5929· DE

Description

VANDETANIB

First action · last action
2011-11-16 · 2013-02-14
Transactions
3
First transaction's obligation
$88,017
Base + all options value (sum of deltas)
$119,291
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5882X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$139,355$0Base award · 2011-11-16 · this action $88,017 · running total $88,017Modification P00001 · 2012-08-02 · this action $51,338 · running total $139,355Modification P00002 · 2013-02-14 · this action -$20,064 · running total $119,291
  • Base2011-11-16+$88,017= $88,017
  • Mod P000012012-08-02+$51,338= $139,355
  • Mod P000022013-02-14-$20,064= $119,291
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-11-16+$88,017$88,017VANDETANIB
Mod P00001· FUNDING ONLY ACTION2012-08-02+$51,338$139,355VANDETANIB
Mod P00002· CLOSE OUT2013-02-14−$20,064$119,291VANDETANIB

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FBWCB39K5929)

AwardOffice · PSC / listingNet obligationsFY
VA24117F0409241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$62,720FY2017
VA24916J2992596-LEXINGTON(00596) · 6505 · DRUGS AND BIOLOGICALS$9,360FY2016
VA24816F1925248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$7,567FY2016
VA24916J2473626-NASHVILLE (00626) · 6505 · DRUGS AND BIOLOGICALS$10,442FY2016
VA24916J2234596-LEXINGTON(00596) · 6505 · DRUGS AND BIOLOGICALS$0FY2016
VA24816F1550248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$7,567FY2016

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26016F0697LUNDBECK LLC260-NETWORK CONTRACT OFFICE 20$6,829FY2016
VA26016F0673UNITED THERAPEUTICS CORP260-NETWORK CONTRACT OFFICE 20$8,906FY2016
VA26016J0622SANOFI VACCINES US INC.260-NETWORK CONTRACT OFFICE 20$396,690FY2016
VA26016J0621SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$176,120FY2016
VA26016J0613SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$74,617FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26012F0102_3600_V797P5882X_3600 · retrieved 2026-09-26.